TRANSTHERA-B (02617) announced that its board of directors received a resignation letter dated March 31, 2026, from the company's independent non-executive director, Ms. Zheng Zhelan. Due to personal work arrangements, Ms. Zheng has decided to resign from her positions as independent non-executive director, chair of the board's remuneration and assessment committee, and member of the board's audit and nomination committees. Her resignation will take effect following the election of a new independent non-executive director at the upcoming annual general meeting. Until that time, she will continue to perform her duties in all her current roles.

Following a qualification review by the nomination committee, the board of directors convened on March 31, 2026, and reviewed and approved the proposal to appoint Mr. Feng Weibo as an independent non-executive director. The board agreed to nominate Mr. Feng as a candidate for independent non-executive director, who will also serve as chair of the remuneration and assessment committee and as a member of the audit and nomination committees. His term will commence upon approval at the forthcoming annual general meeting and will last for a period of three years.

Separately, the board received a resignation letter dated March 31, 2026, from the company's non-executive director, Dr. Yi Hua. Dr. Yi, who was appointed as a director by a shareholder of the company, has decided to resign from his role as non-executive director, taking into account arrangements related to the shareholder he represents and his personal work schedule. Dr. Yi's resignation is effective immediately.